Skip to content

13F-HR/A filed by PIPER SANDLER & CO.

PIPER SANDLER & CO. filed this 13F-HR/A for the quarter ended 2022-12-31, filed 2023-02-24, with 34 holding rows worth $96,553,101.

Accession
0000724683-23-000012
Filed
2023-02-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, amendment of type restatement, 35 entries on the cover page, a total value of $96,553,101 stated on the cover page (in dollars after the unit check, H1), rows summing to $96,553,101 with VALUE read as dollars as filed, 13F file number 028-15951. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NOVAVAX INC670002AB0NOTE 3.750% 2/019,748,000$19,588,041dollars as filedprincipal
ATLAS AIR WORLDWIDE HLDGS IN049164BJ4NOTE 1.875% 6/07,250,000$12,097,833dollars as filedprincipal
KKR REAL ESTATE FIN TR INC48251KAB6NOTE 6.125% 5/111,164,000$10,956,573dollars as filedprincipal
BLACKSTONE MTG TR INC09257WAC4NOTE 4.750% 3/19,838,000$9,647,438dollars as filedprincipal
HOPE BANCORP INC43940TAB5NOTE 2.000% 5/17,919,000$7,736,863dollars as filedprincipal
STARWOOD PROPERTY TRUST85571BAH8Convertible Debt6,639,000$6,435,714dollars as filedprincipal
COLONY FINL INC19624RAA4NOTE 5.000% 4/16,184,000$6,091,240dollars as filedprincipal
THERAVANCE INC88338TAB0CORPORATE OBLIG4,233,000$4,227,920dollars as filedprincipal
SUPERNUS PHARMACEUTICALS868459AD0BOND4,095,000$4,023,338dollars as filedprincipal
APOLLO COML REAL ESTATE FIN03762UAC9BOND3,349,000$3,256,903dollars as filedprincipal
TERADYNE INC880770AG7NOTE1,352,000$2,851,503dollars as filedprincipal
ANTHEM INC94973VBG1NOTE 2.750%10/1350,000$2,350,530dollars as filedprincipal
NUTANIX INC67059NAB4NOTE 1/11,902,000$1,873,470dollars as filedprincipal
ILLUMINA INC452327AK5NOTE 8/11,290,000$1,246,114dollars as filedprincipal
INTERCEPT PHARMACEUTICALS IN45845PAA6NOTE 3.250% 7/01,162,000$1,139,110dollars as filedprincipal
PATRICK INDS INC703343AB9DBCV 1.000% 2/0423,000$419,024dollars as filedprincipal
SLAM CORPG8210L105COM25,100$253,510dollars as filed
ABG ACQUISITION CORP IG00496102CL A SHS25,000$252,250dollars as filed
LOGISTIC PROPERTIES OF THE AME USD ORD SHSG9152V101Stock25,003$252,155dollars as filed
COLOMBIER ACQUISITION CORP19533H108COM25,000$248,500dollars as filed
DA32 LIFE SCNCE TEC ACQSTN C23312M106CLASS A COM25,003$247,530dollars as filed
TILRAY BRANDS INC88688TAB6NOTE 5.000%10/0235,000$231,072dollars as filedprincipal
PROFRAC HLDG CORP74319N100CLASS A COM8,164$205,733dollars as filed
VEECO INSTRS INC DEL922417AD2NOTE 2.700% 1/1199,000$196,314dollars as filedprincipal
VECTOR ACQUISITION CORP IIG9460A104CL A SHS16,888$170,569dollars as filed
OPPFI INC68386H103COMMON STOCK59,438$121,848dollars as filed
REDWOOD TRUST INC758075AC9BOND100,000$99,334dollars as filedprincipal
SHATTUCK LABS INC82024L103COMMON STOCK39,467$90,774dollars as filed
Cartesian Growth Corp IIG19305120Warrant402,500$90,522dollars as filed
NEW RELIC INC64829BAB6NOTE 0.500% 5/072,000$70,416dollars as filedprincipal
FINTECH EVOLUTION ACQUIS GROG3R19A104SHS CL A5,705$57,621dollars as filed
LIGAND PHARMACEUTICALS INC53220KAF5NOTE 0.750% 5/113,000$12,651dollars as filedprincipal
SILK ROAD MEDICAL INC82710M100COMMON STOCK146$7,716dollars as filed
Oppfi Inc W Exp 07/20/20268386H111SPAC Combination29,719$2,972dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000724683-23-000011 superseded2023-02-13acceptance time not in the bulk data set
13F-HR/A 0000724683-23-000012this filing2023-02-24acceptance time not in the bulk data set